998 related articles for article (PubMed ID: 9297994)
21. Antihypertensive therapy in elderly patients with isolated systolic hypertension: third progress report of the Syst-Eur trial.
Thijs L; Amery A; Antikainen R; Bert P; Birkenhäger W; Bulpitt CJ; Dollery CT; Fletcher AE; Forette F; Hakamäki T
Clin Exp Hypertens; 1993 Nov; 15(6):953-66. PubMed ID: 8268900
[TBL] [Abstract][Full Text] [Related]
22. Trials in elderly patients with isolated systolic hypertension.
Staessen J; Guo C; Celis H; Fagard R; Thijs L; Amery A
Chin Med J (Engl); 1992 May; 105(5):364-8. PubMed ID: 1499364
[TBL] [Abstract][Full Text] [Related]
23. Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators.
Staessen JA; Thijs L; Bieniaszewski L; O'Brien ET; Palatini P; Davidson C; Dobovisek J; Jääskivi M; Laks T; Lehtonen A; Vanhanen H; Webster J; Fagard R
Hypertension; 1996 Mar; 27(3 Pt 1):414-20. PubMed ID: 8698447
[TBL] [Abstract][Full Text] [Related]
24. Randomised double-blind comparison of placebo and active drugs for effects on risks associated with blood pressure variability in the Systolic Hypertension in Europe trial.
Hara A; Thijs L; Asayama K; Jacobs L; Wang JG; Staessen JA
PLoS One; 2014; 9(8):e103169. PubMed ID: 25090617
[TBL] [Abstract][Full Text] [Related]
25. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.
Philipp T; Anlauf M; Distler A; Holzgreve H; Michaelis J; Wellek S
BMJ; 1997 Jul; 315(7101):154-9. PubMed ID: 9251545
[TBL] [Abstract][Full Text] [Related]
26. Risk reduction associated with lowering systolic blood pressure: review of clinical trial data.
Hall WD
Am Heart J; 1999 Sep; 138(3 Pt 2):225-30. PubMed ID: 10467217
[TBL] [Abstract][Full Text] [Related]
27. Implications of the Systolic Hypertension in China trial.
Liu L; Wang JG; Celis H; Staessen JA
Clin Exp Hypertens; 1999; 21(5-6):499-505. PubMed ID: 10423076
[TBL] [Abstract][Full Text] [Related]
28. [Antihypertensive treatment and prevention of dementia].
Seux ML
Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):512-7. PubMed ID: 12555375
[TBL] [Abstract][Full Text] [Related]
29. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
JAMA; 1991 Jun; 265(24):3255-64. PubMed ID: 2046107
[TBL] [Abstract][Full Text] [Related]
30. Nitrendipine and enalapril combination therapy in mild to moderate hypertension: assessment of dose-response relationship by a clinical trial of factorial design.
Roca-Cusachs A; Torres F; Horas M; Ríos J; Calvo G; Delgadillo J; Terán M;
J Cardiovasc Pharmacol; 2001 Dec; 38(6):840-9. PubMed ID: 11707687
[TBL] [Abstract][Full Text] [Related]
31. Systolic blood pressure reduction with olmesartan medoxomil versus nitrendipine in elderly patients with isolated systolic hypertension.
Mallion JM; Heagerty A; Laeis P
J Hypertens; 2007 Oct; 25(10):2168-77. PubMed ID: 17885562
[TBL] [Abstract][Full Text] [Related]
32. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
Fagard RH; Staessen JA; Thijs L; Gasowski J; Bulpitt CJ; Clement D; de Leeuw PW; Dobovisek J; Jääskivi M; Leonetti G; O'Brien E; Palatini P; Parati G; Rodicio JL; Vanhanen H; Webster J
Circulation; 2000 Sep; 102(10):1139-44. PubMed ID: 10973843
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
34. [SYST-EUR: a multicenter trial of treatment of systolic hypertension in aged subjects. An initial report].
Girerd X; Amery A; Birkenhager W; Bulpitt C; Cox J; De Leeuw P; De Cort P; Fagard R; Fletcher A; Forette F
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1243-7. PubMed ID: 1482267
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of isolated systolic arterial hypertension and prevention of dementia in aged patients. The Syst-Eur multicenter study].
Seux ML; Staessen JA; Forette F
Arch Mal Coeur Vaiss; 1999 Aug; 92(8):1083-7. PubMed ID: 10486670
[TBL] [Abstract][Full Text] [Related]
36. Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization.
Amery A; Birkenhäger W; Bulpitt CJ; Clément D; De Leeuw P; Dollery CT; Fagard R; Fletcher A; Forette F; Leonetti G
Aging (Milano); 1991 Sep; 3(3):287-302. PubMed ID: 1764497
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of antihypertensive drugs on systolic blood pressure.
Chaignon MM; Mourad JJ; Guédon J
J Hypertens Suppl; 1993 Mar; 11(1):S27-31. PubMed ID: 8483018
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
39. [Results of the SYST-EUR study. Isolated systolic hypertension and calcium antagonists].
Faulhaber HD
Fortschr Med; 1997 Nov; 115(32):45-6. PubMed ID: 9480267
[No Abstract] [Full Text] [Related]
40. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.
Amery A; Birkenhäger W; Brixko P; Bulpitt C; Clement D; Deruyttere M; De Schaepdryver A; Dollery C; Fagard R; Forette F
Lancet; 1985 Jun; 1(8442):1349-54. PubMed ID: 2861311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
